Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity

Steven L. Flamm^*, Andrew J. Muir, Michael W. Fried, K. Rajender Reddy, David R. Nelson, Natalie H. Bzowej, James C. Sullivan, Leif Bengtsson, Ralph DeMasi, Christopher I. Wright, Tara L. Kieffer, Shelley George, Nathalie Adda, Geoffrey M. Dusheiko

^*Corresponding author for this work